Researchers launch smartphone platform to monitor senior safety
Sanjay Ranka, Ph.D., and Todd Manini, Ph.D., are on a mission to bring health care for seniors into the smartphone age.
Sanjay Ranka, Ph.D., and Todd Manini, Ph.D., are on a mission to bring health care for seniors into the smartphone age.
Research into gestational diabetes has focused almost entirely on the mother ā her metabolism, her risk factors, her outcomes. Kylie K. Harrall, PhD, thinks thatās only half the picture.
Cancer patients who could benefit from participating in clinical trials may never hear about such opportunities. To overcome this silence, researchers are creating a new chapter for a training program that teaches physicians how to communicate with cancer patients about the value of controlled cancer studies.
University of Florida health researchers are expanding collaboration with Mount Kenya University (MKU), one of the largest private universities in Africa.
A new five-year study of chronic kidney disease in children will draw on University of Florida informatics expertise to investigate how medication and blood pressure monitoring can improve outcomes.
A successful communication skills training program about clinical trials is expanding to cover pediatric cancer. The workshop trains medical oncology fellows to communicate clearly with patients and their families about the benefits of enrolling in a clinical trial.
Dr. Elizabeth āBetsyā Shenkman, Ph.D., has earned the highest honor for a faculty member at the University of Florida: Distinguished Professor. This rare designation denotes the perseverance necessary to reach extraordinary academic achievement and influence.
Yi Guo, Ph.D., is a collaborator on new research that has found an association between taking glucosamine, a popular over-the-counter supplement used for joint pain, and a higher likelihood of progressing from mild cognitive impairment to Alzheimerās disease.
A mother-daughter story of a painful, misunderstood disease is turning into a teachable moment.
McKnight Brain Institute: The project of Yonghui Wu, Ph.D., and Rui Yin, Ph.D., aims to develop innovative computational tools and analytical frameworks to better understand why some Alzheimerās patients progress rapidly and others slowly, to improve future clinical trial design and interventions.